Cargando…

Echocardiographic assessment of the right ventricle in COVID -related acute respiratory syndrome

In patients with the novel coronavirus (COVID-19) infection, the echocardiographic assessment of the right ventricle (RV) represents a pivotal element in the understanding of current disease status and in monitoring disease progression. The present manuscript is aimed at specifically describing the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazzeri, Chiara, Bonizzoli, Manuela, Batacchi, Stefano, Peris, Adriano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492785/
https://www.ncbi.nlm.nih.gov/pubmed/32936380
http://dx.doi.org/10.1007/s11739-020-02494-x
_version_ 1783582432511918080
author Lazzeri, Chiara
Bonizzoli, Manuela
Batacchi, Stefano
Peris, Adriano
author_facet Lazzeri, Chiara
Bonizzoli, Manuela
Batacchi, Stefano
Peris, Adriano
author_sort Lazzeri, Chiara
collection PubMed
description In patients with the novel coronavirus (COVID-19) infection, the echocardiographic assessment of the right ventricle (RV) represents a pivotal element in the understanding of current disease status and in monitoring disease progression. The present manuscript is aimed at specifically describing the echocardiographic assessment of the right ventricle, mainly focusing on the most useful parameters and the time of examination. The RV direct involvement happens quite often due to preferential lung tropism of COVID-19 infection, which is responsible for an interstitial pneumonia characterized also by pulmonary hypoxic vasoconstriction (and thus an RV afterload increase), often evolving in acute respiratory distress syndrome (ARDS). The indirect RV involvement may be due to the systemic inflammatory activation, caused by COVID-19, which may affect the overall cardiovascular system mainly by inducing an increase in troponin values and in the sympathetic tone and altering the volemic status (mainly by affecting renal function). Echocardiographic parameters, specifically focused on RV (dimensions and function) and pulmonary circulation (systolic pulmonary arterial pressures, RV wall thickness), are to be measured in a COVID-19 patient with respiratory failure and ARDS. They have been selected on the basis of their feasibility (that is easy to be measured, even in short time) and usefulness for clinical monitoring. It is advisable to measure the same parameters in the single patient (based also on the availability of valid acoustic windows) which are identified in the first examination and repeated in the following ones, to guarantee a reliable monitoring. Information gained from a clinically-guided echocardiographic assessment holds a clinical utility in the single patients when integrated with biohumoral data (indicating systemic activation), blood gas analysis (reflecting COVID-19-induced lung damage) and data on ongoing therapies (in primis ventilatory settings).
format Online
Article
Text
id pubmed-7492785
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-74927852020-09-16 Echocardiographic assessment of the right ventricle in COVID -related acute respiratory syndrome Lazzeri, Chiara Bonizzoli, Manuela Batacchi, Stefano Peris, Adriano Intern Emerg Med IM-Point of view In patients with the novel coronavirus (COVID-19) infection, the echocardiographic assessment of the right ventricle (RV) represents a pivotal element in the understanding of current disease status and in monitoring disease progression. The present manuscript is aimed at specifically describing the echocardiographic assessment of the right ventricle, mainly focusing on the most useful parameters and the time of examination. The RV direct involvement happens quite often due to preferential lung tropism of COVID-19 infection, which is responsible for an interstitial pneumonia characterized also by pulmonary hypoxic vasoconstriction (and thus an RV afterload increase), often evolving in acute respiratory distress syndrome (ARDS). The indirect RV involvement may be due to the systemic inflammatory activation, caused by COVID-19, which may affect the overall cardiovascular system mainly by inducing an increase in troponin values and in the sympathetic tone and altering the volemic status (mainly by affecting renal function). Echocardiographic parameters, specifically focused on RV (dimensions and function) and pulmonary circulation (systolic pulmonary arterial pressures, RV wall thickness), are to be measured in a COVID-19 patient with respiratory failure and ARDS. They have been selected on the basis of their feasibility (that is easy to be measured, even in short time) and usefulness for clinical monitoring. It is advisable to measure the same parameters in the single patient (based also on the availability of valid acoustic windows) which are identified in the first examination and repeated in the following ones, to guarantee a reliable monitoring. Information gained from a clinically-guided echocardiographic assessment holds a clinical utility in the single patients when integrated with biohumoral data (indicating systemic activation), blood gas analysis (reflecting COVID-19-induced lung damage) and data on ongoing therapies (in primis ventilatory settings). Springer International Publishing 2020-09-16 2021 /pmc/articles/PMC7492785/ /pubmed/32936380 http://dx.doi.org/10.1007/s11739-020-02494-x Text en © Società Italiana di Medicina Interna (SIMI) 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle IM-Point of view
Lazzeri, Chiara
Bonizzoli, Manuela
Batacchi, Stefano
Peris, Adriano
Echocardiographic assessment of the right ventricle in COVID -related acute respiratory syndrome
title Echocardiographic assessment of the right ventricle in COVID -related acute respiratory syndrome
title_full Echocardiographic assessment of the right ventricle in COVID -related acute respiratory syndrome
title_fullStr Echocardiographic assessment of the right ventricle in COVID -related acute respiratory syndrome
title_full_unstemmed Echocardiographic assessment of the right ventricle in COVID -related acute respiratory syndrome
title_short Echocardiographic assessment of the right ventricle in COVID -related acute respiratory syndrome
title_sort echocardiographic assessment of the right ventricle in covid -related acute respiratory syndrome
topic IM-Point of view
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492785/
https://www.ncbi.nlm.nih.gov/pubmed/32936380
http://dx.doi.org/10.1007/s11739-020-02494-x
work_keys_str_mv AT lazzerichiara echocardiographicassessmentoftherightventricleincovidrelatedacuterespiratorysyndrome
AT bonizzolimanuela echocardiographicassessmentoftherightventricleincovidrelatedacuterespiratorysyndrome
AT batacchistefano echocardiographicassessmentoftherightventricleincovidrelatedacuterespiratorysyndrome
AT perisadriano echocardiographicassessmentoftherightventricleincovidrelatedacuterespiratorysyndrome